je.st
news
Tag: usp
Addition Cured Silicone Meets USP Class VI and ISO 10993-5 Specifications for Biocompatibility ...
2013-05-14 06:00:00| Industrial Newsroom - All News for Today
Formulated for medical device applications, MasterSil 153Med passes USP Class VI and ISO 10993-5 testing. This two part silicone with a paste consistency features a convenient one to one mix ratio by weight, and does not require exposure to air and humidity for cross-linking. It has a long working life of 5-7 hours and will not outgas while curing.<br /> <br /> As is true with most silicones, MasterSil 153Med delivers high temperature resistance up to 400°F and superior flexibility. Its ...This story is related to the following:Chemical Processing and Waste ManagementMaterials and Material ProcessingSearch for suppliers of: Silicone Adhesives | Silicone Coated Sleeving | Medical Device Adhesives
Tags: class
addition
specifications
iso
USP & EP 5.1.6 Validation Testing Of IMDA 300/350 Systems
2013-03-19 02:10:53| drugdiscoveryonline Downloads
This fact sheet provides a summary of test parameters and results for BioVigilant’s IMD-A 300 and IMD-A 350 systems based on USP <1223> and EP 5.1.6 validation guidelines.
Tags: systems
testing
validation
usp
USP Purified Water System serves biotech, pharma industries.
2013-01-25 14:30:33| Industrial Newsroom - All News for Today
Used in high-purity/bacteria-controlled applications, BioPure LSX single-skid, single-pass/RO/EDI USP purified water system addresses needs of biotech and pharma water markets. Design accelerates installation, and standard systems are available in flowrates up to 20 gpm. In addition to automated hot water sanitization of system, features include energy conservation technology and automated adjustment of operating parameters in order to optimize operation. This story is related to the following:Ultrapure Water Systems
Tags: system
water
industries
serves
GE Healthcare Files Supplemental New Drug Application For Its Own Manufacturing Of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP)
2013-01-15 13:50:00| drugdiscoveryonline News Articles
GE Healthcare recently announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), within its own facility
Tags: application
files
drug
manufacturing